A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia by Byrd, John C., Marcucci, Guido, Parthun, Mark R., Xiao, Jim J., Klisovic, Rebecca B., Moran, Mollie, Lin, Thomas S., Liu, Shujun, Sklenar, Amy R., Davis, Melanie E., Lucas, David M., Fischer, Beth, Shank, Roshini, Tejaswi, Sooraj L., Binkley, Philip, Wright, John, Chan, Kenneth K., Grever, Michael R.

Get full text

Flavopiridol, Fludarabine and Rituximab Is a Highly Active Regimen in Indolent B-Cell Lymphoproliferative Disorders Including Mantle Cell Lymphoma by Lin, Thomas S., Fischer, Beth, Moran, Mollie E., Buckner, Maureen M., Shank, Roshini, Kraut, Eric H., Porcu, Pierluigi, Farag, Sherif S., Eisenbeis, Charles F., Colevas, Dimitrios, Grever, Michael R., Byrd, John C.

Get full text

Flavopiridol Administered as a Pharmacologically-Derived Schedule Demonstrates Marked Clinical Activity in Refractory, Genetically High Risk, Chronic Lymphocytic Leukemia (CLL) by Byrd, John C., Lin, Thomas S., Dalton, James T., Wu, Di, Fischer, Beth, Moran, Mollie E., Blum, Kristie A., Shank, Roshini S., Lucas, David M., Lucas, Margaret S., Suarez, Jose-Ramon, Grever, Michael R.

Get full text

Phase I Dose Escalation Study of Flavopiridol in Combination with Fludarabine and Rituximab: Activity in Indolent B-Cell Lymphoproliferative Disorders and Mantle Cell Lymphoma by Lin, Thomas S., Fischer, Beth, Moran, Mollie E., Lucas, David M., Shank, Roshini S., Kraut, Eric H., Farag, Sheriff S., Lucas, Margaret S., Colevas, Alexander D., Grever, Michael R., Byrd, John C.

Get full text